TAYLOR PEPPER: Open Payments
NPI 1154965705 · EL DORADO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$322 in 17 payments from 9 companies in 2025. Trend: 2023 $412 · 2024 $278 · 2025 $322
Food & beverage: $322
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $80 |
| Sumitomo Pharma America, Inc. | 3 | $66 |
| Organon LLC | 2 | $45 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Evofem Biosciences, Inc. | 1 | $21 |
| MILLICENT US INC | 1 | $18 |
| Exact Sciences Corporation | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Sage Therapeutics, LLC | 1 | $17 |
Products named: Veozah, MYFEMBREE, NEXPLANON, Auvelity, Phexxi, INTRAROSA, The Cologuard Plus Collection Kit, Qelbree.
Industry payments across AR — which companies pay providers there.
